|
HS Code |
974906 |
| Iupac Name | (2R,3R)-2,3-dihydroxybutanedioic acid 2-anilide |
| Cas Number | 50915-21-6 |
| Molecular Formula | C10H9NO5 |
| Molecular Weight | 223.18 |
| Appearance | White to off-white solid |
| Melting Point | 150-154°C |
| Optical Rotation | [α]D20 +24° (c=1, H2O) |
| Solubility | Soluble in water and ethanol |
| Boiling Point | Decomposes before boiling |
| Chirality | Chiral, (2R,3R) absolute configuration |
| Synonyms | Anilide of (R,R)-Tartaric acid |
| Smiles | C1=CC=C(C=C1)NC(=O)C(C(C(=O)O)O)O |
As an accredited (2R,3R)-Tartranilic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | (2R,3R)-Tartranilic Acid, 10g, is supplied in a tightly sealed amber glass bottle with a tamper-evident cap and label. |
| Shipping | (2R,3R)-Tartranilic Acid is shipped in tightly sealed containers, protected from moisture and light. Packaging complies with chemical safety regulations, using inert materials. Labeled with hazard and handling information, it is transported via ground or air under controlled temperatures. Shipping documentation includes safety data sheets and regulatory compliance details. |
| Storage | (2R,3R)-Tartranilic acid should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, well-ventilated area, ideally under inert atmosphere if prolonged storage is needed. Avoid exposure to incompatible materials such as strong oxidizing agents. Store at room temperature and follow all relevant safety guidelines for handling chemical substances. |
Applications of (2R,3R)-Tartranilic Acid in Industrial ManufacturingAs a specialized manufacturer, we produce (2R,3R)-Tartranilic Acid for high-value industrial sectors demanding stringent stereochemical purity. Its unique configuration supports advanced synthesis requirements in regulated manufacturing environments. Here we detail downstream sectors actively utilizing this chiral raw material, including compliance mandates, standard usage, process entry points, and finished product outputs. 1. Active Pharmaceutical Ingredient (API) Chiral Intermediate Synthesis(2R,3R)-Tartranilic Acid functions as a critical chiral auxiliary in asymmetric synthesis for APIs—particularly in the preparation of optically pure drugs. Leading pharmaceutical producers use this raw material to facilitate stereoselective transformations during the multi-step synthesis of antihypertensives, antiretrovirals, and certain oncology therapies. Its well-defined stereochemistry supports enantioselective alkylation, acylation, and reduction reactions, directly impacting the enantiopurity of the resulting API molecule. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis (Selective Herbicide Intermediate)(2R,3R)-Tartranilic Acid sees targeted use in agrochemical manufacturing, where producers require chiral building blocks for enantioselective formulations. Herbicide synthesis lines employ this compound to create chiral intermediates that enhance field selectivity and minimize crop phytotoxicity. Its defined stereochemistry supports advanced methodologies in the preparation of phenoxy acid-derived herbicides used for selective weed control. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemicals for Flavors and Fragrances (Chiral Aroma Precursor Production)Manufacturers of advanced flavors and fragrances employ (2R,3R)-Tartranilic Acid as a chiral template in the synthesis of key aroma-active compounds. Its controlled stereochemistry supports the construction of optically pure alcohols and esters that impart complex scents and tastes, essential for high-end perfumery and specialty food additives. This application demands consistent, contamination-free production and traceability from raw material to finished blend. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Polymer Synthesis (Chiral Monomer Modifier)In the high-performance polymers sector, (2R,3R)-Tartranilic Acid serves as a chiral modifying agent during monomer synthesis. Manufacturers incorporate it to induce stereoselective properties in polyamides and functional polyesters, enhancing the material’s thermal stability and optical clarity. This driven approach finds application in advanced film, fiber, and specialty engineering plastics manufacturing where end-use demands precise chiral architecture. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Organic Synthesis (Research and Custom Stereoselective Building Blocks)Contract research organizations, specialty fine chemical producers, and custom synthesis labs rely on (2R,3R)-Tartranilic Acid as a foundational chiral building block for high-value syntheses. The compound is utilized to create a variety of bespoke molecules, including pharmaceutical candidates, diagnostic agents, and functionalized ligands for catalysis research. Laboratories depend on its reproducible stereochemistry for method development and scale-up studies that feed directly into commercial manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (2R,3R)-Tartranilic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing (2R,3R)-Tartranilic acid calls for a level of attention and experience not found in every chemical shop. Years on the production line have shown me that the smallest adjustments can alter an entire outcome, whether you’re running a fifty-kilogram batch or scaling to industrial levels. Few compounds challenge a manufacturer the way tartranilic acid does, especially in its pure chiral forms. Chemistry textbooks can lay out the formulas, but the real world brings questions of solvent selection, reaction temperature, and reproducibility. That hands-on work translates directly to value for chemists and manufacturers downstream—every lot delivers what they expect, time and again, because we see each step through with care.
Most people hear “stereochemistry” and picture diagrams on a blackboard, but in our work it means person-hours, troubleshooting, and materials. With (2R,3R)-Tartranilic acid, stereoselectivity rules the day. This diastereomer results from a process fraught with opportunities to lose optical purity—one false move, and you end up with a racemic mess or the wrong pair of isomers entirely. That’s no trivial thing; chiral purity underpins reliability in pharmaceutical synthesis, chiral auxiliaries, and advanced materials. Our process employs both classical resolution and enzymatic transformations where possible because the direct route is not always the safe route. By handling each batch from start to finish, we keep a close eye on the chiral integrity using both polarimetry and NMR. Customers waiting for a shipment know that there won’t be surprises once they open a drum and begin their own synthesis.
Having spent years witnessing supply bottlenecks, it’s clear that narrow expertise in chiral intermediates shapes the pace of entire industries. (2R,3R)-Tartranilic acid doesn’t draw headlines, but for research labs and contract manufacturing organizations, one delay in its arrival can hold up a chain of work worth millions. That’s why as a manufacturer, we plan our output with fail-safes—parallel lines, oversupplied critical reagents, and substantial QC time to check for even low-level contaminants. In the lab, getting the right batch makes a visible difference. Experienced chemists recognize high-quality crystals by sight. Get it wrong, and reactions stall. Having the capacity to make tartranilic acid efficiently keeps innovation moving, not just in pharma synthesis but also in fine chemicals and emerging field trials. When regulatory approval hangs on material consistency, the value of dedicated synthesis surpasses any price war between resellers or short-term traders.
After countless crystallizations and filtrations, you learn to spot the genuine article. The right lot of (2R,3R)-Tartranilic acid forms needle-shaped or plate-like crystals, typically colorless to pale off-white, depending on minor impurities or batch size. While cosmetics don’t drive function, consistent color and clarity reflect a disciplined process. Mishandled acetone washes or poorly timed cooling steps give away the work of inexperienced processors. We monitor every batch’s melting range, checking for sharp transitions that indicate a well-formed solid rather than a heterogeneous mixture. Differences in particle size distribution influence dissolution rates and storage stability. The chemistry keeps us honest: if things shift off-spec at any point, the whole lot goes back for rework, costing real money in lost solvents, time, and waste disposal. All this precision matters so that downstream users spend less time filtering or recrystallizing and more time turning out their own target compounds.
While many in the business ask for “chiral intermediates” and let brokers take care of the details, any veteran knows there’s no such thing as commodity-grade (2R,3R)-Tartranilic acid. Our in-house control labs see every finished lot run on HPLC, chiral columns, and NMR. Outliers stand out; even one peak out of place triggers investigation. Often, it’s small environmental shifts or a change of vessel that explains a blip, but we chase the reason every time. Specifications matter. Labs performing enantioselective synthesis require enantiomeric excess above 99%. For pharma, legal and regulatory guides demand multi-tiered certification at every stage. Only a dedicated manufacturer can keep up with those requirements over months and years, not just isolated lots. Any deviation may ruin the next step of somebody else’s synthesis, so we don’t gamble. Instead of smoothing over shortfalls with “acceptable range” language, we lean hard on total transparency. Decades in production teach the value of honesty: one bad batch travels fast along the grapevine.
Tartranilic acid holds up well in air, but moisture uptake can alter performance in downstream work. We pack in moisture-tight bags inside fiber drums, using desiccant where humidity rises above optimal storage conditions. Any variance in hydration level shifts melting ranges and complicates further reactions—little things matter, so we check each lot before it leaves our shelves. Solubility presents another recurring subject. In water, (2R,3R)-Tartranilic acid shows moderate readiness to dissolve, but poor technique leads to superficial solubilization and ruins yields. Old-school chemists know to mix slowly, control temperature, and never depend on “stirring hard” to get the job done. The details that affect a synthetic workflow often begin at the manufacturer’s site. That’s why understanding tartranilic acid’s reactivity profile and hydration state isn’t academic trivia; it’s the line between a productive day and wasted effort.
All hands along the production line know that safety doesn’t come from a two-page document in a file folder. Handling arylamines and tartrate derivatives involves risk, from inhalation up to larger exposures during vacuum drying or fine sieving. Over the years, we switched to closed systems and engineered local exhaust points, based on direct feedback from staff on what worked, what failed, and where attention wandered. Chemical safety at the manufacturing scale never matches the “ideal” lab setup, so adaptation wins over blind adherence to templates. Hearing that a batch left with no incident means far more than ticking boxes on a form. That trust, built from real-world routine and a track record of incident-free delivery, reassures everyone down the chain. For customers who need proof, we’re fully open to visitor audits—because nothing revealed beats what a person sees, smells, and feels by themselves in the plant.
Through years of working with specialty manufacturers and academic partners, one theme emerges: reliability beats novelty every time. A rare compound like (2R,3R)-Tartranilic acid doesn’t suit every application, but in the hands of an experienced team, it ensures that the planned syntheses behave as designed. Universities and pharmaceutical innovators come back to direct producers rather than middlemen because they’re tired of inconsistency. If a starting material changes its melting point or carries over trace metals, it throws out months of research or puts entire pilot projects on hold. Our own production statistics show reduced rejected lots and rare need for special handling. Less scrap material lifts all boats, spares research dollars, and avoids the messy side of repeated purifications. It’s a simple fact: steady supply of a high-quality chiral precursor lets talented researchers focus on the main event—building what nobody else has built.
(2R,3R)-Tartranilic acid carries a particular weight in asymmetric synthesis and as a chiral resolving agent. The secondary amine and two carboxyl groups make it a strong platform for creating enantiomerically enriched amides, esters, and other derivatives. We’ve supplied this material to customers tackling everything from new anticancer scaffolds to chiral auxiliaries for catalytic hydrogenation. Several groups report smoother couplings when starting from high-purity tartranilic acid, limiting side reactions that can sneak through with less pure alternatives. In our own R&D, we’ve used (2R,3R)-tartranilic acid to make tailor-made ligands for organometallic catalysts, drawing on its chirality to impart selectivity early in the synthetic chain. The applications keep expanding as green chemistry moves into focus: chiral phases, recyclable auxiliaries, and low-load, high-efficiency reactions—all benefit from a predictable, top-grade starting point.
We often field questions about the differences between (2R,3R)-Tartranilic acid and its sibling isomers, like the (2S,3S)-, (2R,3S)-, and (2S,3R)-forms, or about switching to seemingly similar intermediates. The impact can’t be understated—a change in stereochemistry transforms not just optical rotation, but the hands-on course of subsequent reactions. One only needs to review failed scaleups or lost weeks in the lab to see how quickly time, money, and goodwill vanish when the wrong isomer appears. Attempts to substitute alternate tartrate derivatives demand careful assessment: downstream coupling steps, ligand behavior, and purification regimes shift, often in subtle ways that only make trouble later. As the manufacturer, we stick to tight chiral control for (2R,3R), rejecting cross-contamination at source by running dedicated lines and strict cleaning regimens. Others sometimes blend mother liquors across runs to salvage out-of-spec batches, but cutting corners trips up every serious user. Chemists trained in separation will spot any laxity within hours. From firsthand experience, we know that compromised chirality never remains hidden for long.
Walking through our quality lab, you’ll see the difference in how we verify every output, not just a sample from the top of a drum. Replication of NMR and chiral HPLC signatures, visual checks of particle uniformity, and cross-analysis against reference lots build a profile of reproducibility. Projects making the jump from laboratory scale to multi-kilo pilot runs depend on that data. Scaling errors do more than cost money—they can imperil key deadlines and investor confidence. Before any drum leaves our floor, it’s held to standards shaped by years of professional skepticism: trusting a process only as far as the independent test will confirm. This attitude means saying no to half-finished purification or incomplete documentation. Our teams know that a mistake at a basic level ripples outward, slowing research, delaying approvals, and in the worst cases risking people’s safety. The solution: relentless attention to detail, both technical and administrative. If multiple people sign off on an outbound batch, it’s no paperwork exercise. It’s a chain of accountability, ending with a product we’d use in our own lab.
Every batch teaches. Over the decades, small tweaks—changing stirring speed, optimizing pH during resolution, maximizing solvent recovery—have built up into significant improvements. Some lessons come the hard way: a new filter cloth with unintended reactivity, a seemingly trivial change in raw tartrate source, or a subtle off-flavor in a finished lot traced back to a supplier’s batch. Our production workflow incorporates real feedback not just from our own chemists, but from downstream users who offer candid insight on what works and what stalls. Sometimes it’s as simple as switching to a different condenser for better product isolation, sometimes it involves a months-long R&D push. The takeaway: (2R,3R)-Tartranilic acid rewards attention, punishes shortcuts, and leaves no room for “good enough.” Every improvement aimed at greater reproducibility benefits end-users in lower frustration and higher yield at their own bench.
Market shifts challenge every manufacturer, but real flexibility in production keeps the material flowing even in times of volatility. As research priorities pivot—driven by external forces like new pharma pipelines, increased academic output, or emerging markets in enantioselective materials—we pivot with them. This doesn’t mean stockpiling indiscriminately, which just wastes material and raises costs for everyone. Instead, we keep a well-honed sense of which applications pull demand and adjust output with lean inventories and direct communication with our professional users. Experience tells us to avoid letting sales targets override quality concerns or letting logistics triumph over laboratory realities. True manufacturing flexibility comes from a skilled team, robust equipment, and the willingness to halt, inspect, and restart as many times as needed to keep the product right.
No modern plant can ignore its impact on the environment. Early in my career, vents ran freely and wastewaters carried unquantified side streams down the drain. Today, both regulation and conscience demand better. For each kilogram produced, we account for byproducts and implement solvent recycling to the maximum. Our team captures amine vapors, neutralizes acidic runoff, and reuses mother liquors where contamination risk remains acceptably low. Any batch involving tartranilic acid produces waste, some of it hazardous, and that complicates disposal planning. By controlling each parameter tightly, yields improve and environmental load shrinks, benefiting both planet and bottom line. End users increasingly want documentation of green practices not just for regulatory approval but for internal audit. We audit suppliers in turn, encouraging a chain of responsible production all the way back to the raw material. None of this comes cheap, but the long-term payback—fewer fines, easier inspections, improved plant reputation—proves its worth year after year.
Discussions about specialty intermediates often get sidetracked by price negotiation. Cutting costs has its place, but as a manufacturer, value means much more than the lowest sticker. Direct production, rather than brokering or repacking material, enables better price stability for regular buyers and limits market manipulation that can leave researchers stranded. We work on margins set by real-world costs: labor, raw materials, compliance, and inevitable waste. Sometimes that means missing the lowest bid by a few percent, but the difference shows up in reliability and reduced risk for our clients. A long-standing relationship built around direct manufacturing also gives repeat customers insider access to upcoming improvements, early-batch material, and schedule flexibility for urgent jobs. As the market grows more sophisticated, clients recognize that saving pennies can mean losing dollars down the road—to delays, rework, or failed syntheses. We prefer to align pricing with technical performance, so end customers see the payback in fewer headaches and better results.
Our history with tartranilic acid began long before the recent surge in interest for chiral catalysts, advanced pharmaceuticals, or high-performance materials. Investment in better analytical methods, newer reactor designs, and more sustainable process choices continues. Each improvement offers incremental advances that make a noticeable difference to users running high-stakes, no-fail reactions. Out in the market, (2R,3R)-Tartranilic acid stands as a foundational building block in chiral technology. Experience-based production, relentless quality validation, and a willingness to innovate give our direct buyers an edge as they move science into new frontiers. That’s the value only a true manufacturer can deliver—knowing not just what’s in a drum, but how every gram got there, and where it fits in the diverse web of tomorrow’s chemistry.